NCT01407237View on ClinicalTrials.gov

Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2015

Conditions
HIV-infection
Interventions
DRUG

Angiotensin II Infusion

Angiotensin II (Bachem) will be infused at 0.3 ng/kg/min for 30 minutes, then 1.0 ng/kg/min for 30 minutes, then 3.0 ng/kg/min for 30 minutes; at baseline and at each infusion concentration, serum aldosterone will be measured. BP and heart rate will be monitored at baseline and every 2 minutes during the infusion.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01407237 - Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV | Biotech Hunter | Biotech Hunter